Global Monoclonal Antibody Partnering Terms and Agreements Report 2021: Trends in Monoclonal Antibodies Dealmaking in the Biopharma industry Since 2014
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021" report has been added to ResearchAndMarkets.com's offering.
The Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive access to available deals and contract documents for over 1000 monoclonal antibody deals.
The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all monoclonal antibody partnering deals announced since Jan 2014, including financial terms where available, including links to online deal records of actual monoclonal antibody partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
In addition, a comprehensive appendix is provided organized by monoclonal antibody partnering company A-Z, deal type definitions and monoclonal antibody partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of monoclonal antibody technologies and products.
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2021 includes:
Trends in monoclonal antibodies dealmaking in the biopharma industry since 2014
Analysis of monoclonal antibodies deal structure
Access to headline, upfront, milestone and royalty data
Access to over 1000 monoclonal antibodies deal records
The leading monoclonal antibodies deals by value since 2014
Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014
Available deals are listed by:
Company A-Z
Headline value
Stage of development at signing
Deal component type
Monoclonal antibodies type
Companies Mentioned
3SBio
4D Pharma
Abbvie
Abcam
AbCellera
AbCheck
AbClon
Ablexis
Ablynx
Abpro
Abzena
Acceleron Pharma
Accord Healthcare
Achaogen
Acticor Biotech
Actinium Pharmaceuticals
Adaptimmune
Adaptive Biotechnologies
Adimab
Adlai Nortye
Aduro BioTech
Advanced BioScience Laboratories
Advantagene
Advaxis
Aeglea BioTherapeutics
Aevi Genomic Medicine
AffaMed Therapeutics
Affimed Therapeutics
Affinita Biotech
AGC Biologics
Agenus Bio
Agilvax
Aimmune Therapeutics
Alder Biopharmaceuticals
Alector
Alexion Pharmaceuticals
Allergan
Alligator Bioscience
Almirall
Alvogen
Ambrx
Amgen
Amneal Pharmaceuticals
AnaptysBio
AnGes MG
Anthera Pharmaceuticals
Antidote Therapeutics
Antigen Express
Antitope
Apceth
Apeiron Biologics
Aperion Biologics
Apexigen
Arcus Biosciences
arGEN-X
argenx
Aridis Pharmaceuticals
ARMO Biosciences
Array Biopharma
Arsanis Biosciences
Ascenion
Ascentage Pharma
Aslan Pharma
Astellas Pharma
Astex Pharmaceuticals
AstraZeneca
Atara Biotherapeutics
Athenex
Atlab Pharma
AvantGen
AVEO Oncology
Avid Bioservices
Avidity Biosciences
Aytu BioScience
Back-A-Line
Basilea Pharmaceutica
Bavarian Nordic
Baxalta
Bayer
Bayer Healthcare
Baylor Institute for Immunology Research
BB100
BeiGene
BerGenBio
Berkeley Lights
Biametrics
Bill and Melinda Gates Foundation
Bio-Thera Solutions
BioArctic Neuroscience
BioAtla
Biocare Medical
Bioceros
BiocerOX Products
Biodesix
BioDuro
Biofactura
Bio Farma
Biogen
BioInvent
BiolineRX
BioMarker Strategies
Biomedical Advanced Research and Development Authority
Biomunex Pharmaceuticals
BioRap Technologies
Biothera
BioXcel
BliNK Biomedical
BliNK Therapeutics
Boehringer Ingelheim
Brigham and Women's Hospital
Bristol-Myers Squibb
C-Bridge Capital
C2N Diagnostics
Caliber Biotherapeutics
Calithera Biosciences
Calypso Biotech
Cancer Prevention and Research Institute of Texas
Cancer Research Technology
Cancer Research UK
Catalent Pharma Solutions
CBT Pharmaceuticals
CDI Laboratories
Celexion
Celgene
Celimmune
Celldex Therapeutics
Cellectis
Cell Marque
Cellmid
Cell Signaling Technology
Celltrion
Center for iPS Cells Research and Application
Centre for Drug Research and Development (CDRD)
Checkmate Pharmaceuticals
Chiome Bioscience
Chugai Pharmaceutical
Cilag AG
Cipla
City of Hope
Clal Biotech
Clinica Universidad Navarra
Clovis Oncology
CMC Biologics
Coherus Biosciences
Cold Genesys
Columbia University
Complement Pharma
Compugen
Conkwest
ContraFect
Cook Pharmica
Corvidia Therapeutics
Corvus Pharmaceuticals
Covalab
Crescendo Biologics
Crown Bioscience
CR Pharma
Crystal Bioscience
CSL
CSPC Pharmaceutical Group
CStone Pharmaceuticals
Cullinan Oncology
Curant Health
CureTech
Curie-Cancer
Cytodyn
CytomX Therapeutics
Cytovance Biologics
Daiichi Sankyo
Dako
Debiopharm
DecImmune Therapeutics
Defense Advanced Research Projects Agency
Defyrus
Denali Therapeutics
DendroCyte
Department of Health and Human Services
Dermira
Distributed Bio
DNAtrix
Dyadic International
Dynavax Technologies
EA Pharma
Eddingpharm
eFFECTOR Therapeutics
EirGenix
Eisai
Eleven Biotherapeutics
Eli Lilly
ElsaLys Biotech
EluSys Therapeutics
EMD Millipore
EMD Serono
Emergent BioSolutions
Enthera
Enumeral Biomedical
Enzo Biochem
Epirus Biopharmaceuticals
EpiThany
Essex Bio-Technology
Eureka Therapeutic
Eurofarma
EUSA Pharma
Eutilex
Everest Medicines
Faron Pharmaceuticals
Fate Therapeutics
Ferring Pharmaceuticals
Five Prime Therapeutics
FLX Bio
Food and Drug Administration (FDA)
Formosa Laboratories
Forty Seven
Fred Hutchinson Cancer Research Center
Fresenius Kabi Pharmaceuticals
Fuhong Hanlin
Fujifilm Kyowa Kirin Biologics
Galapagos
Galaxy Biotech
Galderma
Gallus Biopharmaceuticals
GamaMabs Pharma
Genagon Therapeutics
Genentech
GeNeuro
Geneva Foundation
Genexine
Gen Ilac
Genmab
Genor Biopharma
Georgetown University
Gilead Sciences
GlaxoSmithKline
Glenmark Pharmaceuticals
Global Blood Therapeutics
Glycocept
Glycotope Biotechnology
Glythera
Goodwin Biotechnology
Gradalis
Gritstone Oncology
GTP Technology
H-Immune
H3 Biomedicine
Hadasit Bioholdings
Halozyme Therapeutics
HanAll Pharmaceuticals
Harbour Antibodies
Harbour Biomed
Harvard Pilgrim Health Care
Heidelberg Pharma
Henlius Biotech
Heptares Therapeutics
HiFiBio
Hikma Pharmaceuticals
Hoffmann La Roche
Hope Medicine
Horizon Discovery
Hospira
Humabs BioMed
Humanigen
Hummingbird Bioscience
Hutchison MediPharma
i2 Pharmaceuticals
IBA Molecular Imaging
iBio
Icahn School of Medicine at Mount Sinai
Ichor Medical Systems
iDD Biotech
Idera Pharmaceuticals
Illumina
Imab
ImaginAb
Immatics Biotechnologies
Immune Design
Immune Pharmaceuticals
ImmuNext
ImmunoChina Pharmaceuticals
Immunocore
ImmunoGen
Immunomedics
Immunomic
Immunovaccine
Immutep
IMPACT Therapeutics
Incyte
InDevR
Infinity Pharmaceuticals
Innate Pharma
Innovate UK
Innovent Biologics
Inovio Pharmaceuticals
Inserm
Inserm Transfert
Institut Curie
Institute of Biophysics
Institut Pasteur
Intarcia Therapeutics
Integral Molecular
International Consortium on Anti-Virals
Invenra
IO Biotech
IONTAS
Ipca Laboratories
ISA Pharmaceuticals
IsoTherapeutics
Israel Institute for Biological Research
iTeos Therapeutics
Izana Bioscience
Janssen Biotech
Janssen Pharmaceuticals
Janssen Research & Development
Janssen Sciences
Jazz Pharmaceuticals
JHL Biotech
Jiangsu Hengrui Medicine
Johns Hopkins University
Johnson & Johnson
Johnson & Johnson Innovation
Jounce Therapeutics
Juno Therapeutics
Junshi Biosciences
Kadmon Pharmaceuticals
Kelun-Biotech Biopharmaceutical
Kite Pharma
Kodiak Sciences
Kolltan Pharmaceuticals
Kymab
Kyoto University
Kyowa Hakko Kirin
Laboratoires Thea
Laboratorios Liomont
LA Cell
LakePharma
Leaf Biopharmaceutical
Leap Therapeutics
Lee's Pharmaceutical
Leica Biosystems
LEO Pharma
Les Laboratoires Servier
Leukemia & Lymphoma Society
LG Life Sciences
Libbs Farmaceutica
LifeArc
Ligand Pharmaceuticals
Livzon Mabpharm
Lonza
Lpath
Lupagen
Lupin
Lupus Therapeutics
MAB Discovery
Mabion
MabQuest
Mabspace Bioscience
MabVax Therapeutics
mAbXience
Macquarie University
Macrogenics
Magenta Therapeutics
Mapp Biopharmaceutical
Massachusetts General Hospital
Mayo Clinic
MD Anderson Cancer Center
Medgenics
Medicago
Medigen Biotechnology
MedImmune
Mediolanum
Mediomics
Medison Pharma
Medivation
Memorial Sloan Kettering Cancer Center
Merck and Co
Merck KGaA
Merck Sharpe & Dohme
Merrimack Pharmaceuticals
Mersana Therapeutics
MicroConstants
MiniVax
Minomic
Mitra Biotech
Mitsubishi Tanabe Pharma
ModiQuest Research
Momenta Pharmaceuticals
MorphoSys
Morphotek
Mylan Laboratories
Mylan Pharmaceuticals
Myriad Genetics
NantBioScience
NantCell
NantKwest
Nantong Jinghua Pharmaceutical
NantWorks
Nanyang Technological University
Nascent Biotech
National Cancer Institute
National Center for Advancing Translational Sciences (NCATS)
National Center for Tumor Diseases
National Comprehensive Cancer Network (NCCN)
National Heart
Lung and Blood Institute
National Institute for Viral Sidease Control and Prevention
National Institute of Allergy and Infectious Diseases
National Institute of Standards and Technology
National Institutes of Health
NCIC Clinical Trials Group
Nektar Therapeutics
NeoBiotechnologies
NeoImmuneTech
Neon Therapeutics
NeuClone
Neurimmune Therapeutics
Neuroblastoma and Medulloblastoma Translational Research
Newlink Genetics
Newsummit Biopharma
Nexvet
Northern Biologics
Northwestern University
NovaRock Biotherapeutics
Novartis
Novasep
Novelogics Biotechnology
NovImmune
Novo Nordisk
Noxxon Pharma
Numab
Ohio Clinical Trials Collaborative
Ology Bioservices
Olympic Protein Technologies
Oncobiologics
OncoCare Therapeutics
OncoImmune
Oncologie
Oncolytics Biotech
OncoMed Pharmaceuticals
OncoQuest
OncoSec Medical
Oncosynergy
Oncothyreon
Oncternal Therapeutics
Oncurious
Ono Pharmaceutical
Open Monoclonal Technology
Opthea
Organic Vaccines
OSE Immunotherapeutics
Otsuka
Oxford BioTherapeutics
PacificGMP
Pall Corporation
Pamlico Biopharma
Panacea Pharmaceuticals
Pandion Therapeutics
PATH Malaria Vaccine Initiative
PDS Biotechnology
Pelican Therapeutics
Peregrine Pharmaceuticals
Perelman School of Medicine
Personal Genome Diagnostics
Pfenex
Pfizer
PharmAbcine
Pharmacyclics
PharmaPraxis
Pierre Fabre
PlantForm
Polpharma
Portal Instruments
Poseida Therapeutics
Potenza Therapeutics
Precision Biologics
Prestige BioPharma
Probiodrug AG
ProBioGen
Progenics Pharmaceuticals
Prothena Biosciences
ProtoKinetix
Provention Bio
PULSALYS
Purolite
Q Therapeutics
Quantum Leap Health Care Collaborative
Queensland Institute of Medical Research (QIMR)
Quest PharmaTech
Regeneron Pharmaceuticals
Rentschler Biotechnologie
Repligen
Rexahn Pharmaceuticals
Rezolute
Ridgeback Biotherapeutics
River Vision Development
Roche
Rockefeller University
Rockland Immunochemicals
Roivant Sciences
Roswell Park Cancer Institute
RuiYi
SAB Therapeutics
Samsung Bioepis
Samsung Biologics
San Diego Biomedical Research Institute
Sanofi
Sanofi-Aventis
Sanofi-Pasteur
Sarah Cannon Research Institute
SATT Sud-Est
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
Schrodinger
Sea Lane Biotechnologies
Seattle Genetics
Selexis
SELLAS Life Sciences Group
Serum Institute of India
Sevion Therapeutics
ShanghaiTech University
Shenzhen Arimab Biopharmaceuticals
Shenzhen Chipscreen Biosciences
Shenzhen Hepalink Pharmaceutical
Shire Pharmaceuticals
Simon Fraser University
Small Business Innovation Research
Solentim
Sorrento Therapeutics
Stanford University
Strata Oncology
Strox Biopharmaceuticals
Sun Pharmaceutical
Surface Oncology
Swedish Orphan
Swedish Orphan Biovitrum
Symphogen
Syndax Pharmaceuticals
Syros Pharmaceuticals
Taiho
TaiMed
Taiwan Ministry of Economic Affairs
Takeda Pharmaceutical
Tanabe Research Laboratories
TARIS Biomedical
Telix Pharmaceuticals
TeneoBio
Tesaro
Tessa Therapeutics
Tetragenetics
TetraLogic Pharmaceuticals
Teva Pharmaceutical Industries
TG Therapeutics
Theradiag
Theranyx
Theravectys
ThromboGenics
Tikcro Technologies
Tiziana Life Sciences
Tizona Therapeutics
Tmunity Therapeutics
Torque Therapeutics
TOT BIOPHARM
TRACON Pharmaceuticals
TransBio
Transcenta
Transgene
TransPerfect Life Sciences
Transporin
Trellis Bioscience
Tri-Institutional Therapeutics Discovery Institute
Trianni
Trieza Therapeutics
Turgut Ilaclari
UCB
UMass Memorial Medical Center
Unilife
Universite Claude Bernard Lyon
University College London
University of British Columbia
University of California
San Diego
University of California Los Angeles
University of California San Francisco
University of Cologne
University of Illinois at Chicago
University of Maryland Baltimore
University of Massachusetts Medical School
University of Minnesota
University of Nottingham
University of Pennsylvania
University of Rochester
University of Texas
University of Wisconsin Carbone Cancer Center (UWCCC)
Unum Therapeutics
Uppsala University
US Government
Utrecht University
Vaccinex
Valeant Pharmaceuticals
Valneva
Vaximm
Vect-Horus
Vedanta Biosciences
Ventana Medical Systems
Verastem
Verseau Therapeutics
VIB
Vical
Viela Bio
Vinnova
Viralytics
Virbac
Vir Biotechnology
Visterra
Vitaeris
Voyager Therapeutics
Vyriad
Wilex
Wistar Institute
World Health Organization
WuXi Biologics
XBiotech
Xbrane Bioscience
xCella Biosciences
Xencor
Xoma
Yale University
Yeda Research and Development Company
Yissum Research Development
YL Biologics
Yoshindo
ZAI Laboratory
Zenoaq
Zenyaku Kogyo
Zhejiang Bossan Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zoetis
Zymeworks
For more information about this report visit https://www.researchandmarkets.com/r/hwp8be
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900